Editorial: Targeted alpha particle therapy in oncology.
作者信息
Bruland Øyvind Sverre, Larsen Roy Hartvig, Baum Richard Paul, Juzeniene Asta
机构信息
Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
出版信息
Front Med (Lausanne). 2023 Mar 7;10:1165747. doi: 10.3389/fmed.2023.1165747. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Targeted alpha particle therapy in oncology.社论：肿瘤学中的靶向α粒子疗法
Front Med (Lausanne). 2023 Mar 7;10:1165747. doi: 10.3389/fmed.2023.1165747. eCollection 2023.
2
Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice.二氯化镭-223用于前列腺癌：靶向α治疗在临床实践中应用的原理验证
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):192-217. doi: 10.1007/s00259-019-04475-5. Epub 2019 Aug 30.
3
Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications.靶向α治疗：放射性核素生产、放射化学及应用的进展
Pharmaceutics. 2020 Dec 31;13(1):49. doi: 10.3390/pharmaceutics13010049.
4
Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories.在加拿大核实验室建造钍/锕发生器。
Appl Radiat Isot. 2020 Oct;164:109262. doi: 10.1016/j.apradiso.2020.109262. Epub 2020 Jun 15.
5
An Appendix of Radionuclides Used in Targeted Alpha Therapy.靶向α治疗中使用的放射性核素附录。
J Med Imaging Radiat Sci. 2019 Dec;50(4 Suppl 1):S58-S65. doi: 10.1016/j.jmir.2019.06.051. Epub 2019 Aug 16.
6
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight".靶向α治疗最有前景的放射性核素概述：“八大希望之星”
Pharmaceutics. 2021 Jun 18;13(6):906. doi: 10.3390/pharmaceutics13060906.
7
Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.靶向 α 粒子治疗的进展。我们从体内发生器中了解到的放射性核素发射。
Molecules. 2018 Mar 5;23(3):581. doi: 10.3390/molecules23030581.
8
[Research and Development of 211At-MABG, 225Ac Production, and Anti-Podoplanin Antibody Therapy in Japan].[日本211At-MABG的研发、225Ac的生产及抗血小板内皮细胞黏附分子抗体治疗]
Gan To Kagaku Ryoho. 2022 Aug;49(8):826-828.
9
Production of high-purity radium-223 from legacy actinium-beryllium neutron sources.从传统锕铍中子源生产高纯度镭-223。
Curr Radiopharm. 2012 Jul;5(3):244-52. doi: 10.2174/1874471011205030244.
10
Selective separation of radium and actinium from bulk thorium target material on strong acid cation exchange resin from sulfate media.在硫酸盐介质中，利用强酸性阳离子交换树脂从大量钍靶材料中选择性分离镭和锕。
Appl Radiat Isot. 2018 Oct;140:18-23. doi: 10.1016/j.apradiso.2018.06.008. Epub 2018 Jun 21.
引用本文的文献
1
Eighteen-Months Safety and Efficacy Following Intraperitoneal Treatment With Radium-Labeled Microparticles After CRS-HIPEC in Patients With Peritoneal Metastasis From Colorectal Cancer.结直肠癌腹膜转移患者CRS-HIPEC术后腹腔内注射镭标记微粒18个月的安全性和有效性
J Surg Oncol. 2024 Nov;130(6):1395-1402. doi: 10.1002/jso.27897. Epub 2024 Oct 20.
2
APR-246 as a radiosensitization strategy for mutant p53 cancers treated with alpha-particles-based radiotherapy.APR-246 作为一种放射增敏策略，用于治疗携带突变型 p53 基因的癌症的基于 α 粒子的放射治疗。
Cell Death Dis. 2024 Jun 18;15(6):426. doi: 10.1038/s41419-024-06830-3.
3
In vivo stable At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure.使用新戊二醇结构的体内稳定镥标记的前列腺特异性膜抗原靶向示踪剂。
EJNMMI Radiopharm Chem. 2024 Jun 17;9(1):48. doi: 10.1186/s41181-024-00278-8.
4
Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer.超越平均水平：骨转移前列腺癌中的 α 粒子分布和剂量异质性。
J Nucl Med. 2024 Feb 1;65(2):245-251. doi: 10.2967/jnumed.123.266571.
本文引用的文献
1
Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients receiving Concomitant Ac-DOTATATE Targeted Alpha Therapy and Capecitabine: A Real-world Scenario Management Based Long-term Outcome Study.接受醋酸奥曲肽靶向α治疗与卡培他滨联合治疗的转移性胃肠胰神经内分泌肿瘤患者的生存结局：一项基于真实世界情景管理的长期结局研究。
J Nucl Med. 2022 Jul 21. doi: 10.2967/jnumed.122.264043.
2
Revisiting the Radiobiology of Targeted Alpha Therapy.重新审视靶向α粒子治疗的放射生物学
Front Med (Lausanne). 2021 Jul 27;8:692436. doi: 10.3389/fmed.2021.692436. eCollection 2021.
3
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight".靶向α治疗最有前景的放射性核素概述：“八大希望之星”
Pharmaceutics. 2021 Jun 18;13(6):906. doi: 10.3390/pharmaceutics13060906.
4
Drugmakers go nuclear, continuing push into radiopharmaceuticals.制药商全力投入，继续进军放射性药物领域。
Nat Biotechnol. 2021 Jun;39(6):647-649. doi: 10.1038/s41587-021-00954-z.
5
Improved Formulation of Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP.通过表面层包封和添加乙二胺四亚甲基膦酸改进镭标记碳酸钙微粒的配方
Pharmaceutics. 2021 Apr 29;13(5):634. doi: 10.3390/pharmaceutics13050634.
6
Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications.靶向α治疗：放射性核素生产、放射化学及应用的进展
Pharmaceutics. 2020 Dec 31;13(1):49. doi: 10.3390/pharmaceutics13010049.
7
Bone health in cancer: ESMO Clinical Practice Guidelines.癌症中的骨骼健康：ESMO临床实践指南
Ann Oncol. 2020 Dec;31(12):1650-1663. doi: 10.1016/j.annonc.2020.07.019. Epub 2020 Aug 12.
8
Radiotheranostics: a roadmap for future development.放射治疗学：未来发展的路线图。
Lancet Oncol. 2020 Mar;21(3):e146-e156. doi: 10.1016/S1470-2045(19)30821-6.
9
Are 90% of deaths from cancer caused by metastases?癌症导致的死亡中，90%是由转移引起的吗？
Cancer Med. 2019 Sep;8(12):5574-5576. doi: 10.1002/cam4.2474. Epub 2019 Aug 8.
10
Radioactive drugs emerge from the shadows to storm the market.放射性药物走出阴影，席卷市场。
Nat Biotechnol. 2018 Dec 6;36(12):1125-1127. doi: 10.1038/nbt1218-1125.
Zotero 插件